Awaiting development: Guidance and quality standards
Showing 1 to 4 of 4
Title | Type |
---|---|
Ensitrelvir for treating COVID 19 [ID6231] | Technology appraisal guidance |
Remdesivir for treating COVID 19 [ID3808] | Technology appraisal guidance |
Sabizabulin for treating COVID 19 TS ID 11814 | Technology appraisal guidance |
Vilobelimab for treating COVID 19 TS ID 11815 | Technology appraisal guidance |